(Note: Laris Media Acquisition Corp. withdrew its SPAC IPO in an SEC filing dated April 19, 2022; the S-1 filed on March 19, 2021.) We intend to focus our search for a target business operating in the audio industry in North America. (Incorporated in the Cayman Islands) We are focused on identifying a business combination target […]

We intend to focus on operating businesses in the biotechnology or telecommunications, media, and technology, or TMT, industries in Asia and North America, evaluated based on, among other things, sustainability and environmental, social, and corporate governance, or ESG, imperatives. (Incorporated in the Cayman Islands)

(Note: Reborn Coffee, Inc. upsized its IPO at pricing on Aug. 11, 2022, to 1.44 million shares, up from 1.2 million in the prospectus, and priced the IPO at $5.00, the assumed IPO price, to raise $7.2 million. The stock is expected to start trading Friday, Aug. 12, 2022, on the NASDAQ. The timing of […]

(Note: Foresite Life Sciences Corp., a SPAC or blank-check company, withdrew its stock-only SPAC IPO in an SEC filing dated April 15, 2022. The company filed its S-1 (prospectus) on Feb. 26, 2021; it filed its last S-1/A on May 6, 2021. Most SPAC IPOs are unit offerings of stock and warrants. Foresite Life Sciences […]

(Note: ForU Worldwide Inc. withdrew its IPO in an SEC filing dated April 19, 2022. This was an IPO of American Depositary Shares (ADS), with no pricing terms stated, according to an F-1/A filing dated June 2, 2021. The F-1 (prospectus) was filed May 13, 2021. ForU Worldwide filed confidentially for an IPO on March […]

  We are a clinical biopharmaceutical company focused on developing and commercializing novel vaccines. Our initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection. It is estimated that norovirus causes nearly 700 million cases of illness and more than 200,000 deaths worldwide per year, as well […]

We are a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. Our Enhanced Delivery Oligonucleotide, or EDO, platform is founded on over a decade of research and development and leverages cell-penetrating peptides to improve the uptake and activity of conjugated […]

(The company is not selling any stock in this IPO – and as a result, the company will not receive any proceeds from this IPO. The S-1 filing (prospectus) states that all shares of Class A common stock sold in this IPO are being offered by the selling stockholders: John Paulson, Paulson Advantage Master Ltd. […]

Tenon Medical, Inc. (“Tenon”), a medical device company formed in 2012, has developed a proprietary U.S. Food and Drug Administration (“FDA”) cleared surgical implant system, which is designed to optimize sacroiliac joint (“SI-Joint”) fixation / fusion surgery and corresponding outcomes. Tenon is preparing a national launch of this system to address the greatly underserved market […]

(Note: This is NOT an IPO. This is a NASDAQ uplisting from the OTCQB Marketplace. IPOScoop has NO CALL on uplistings.) (Note: SOBR Safe, Inc. announced the pricing of its public offering on Friday, May 13, 2022, at downsized terms: 2.35 million units (vs. 2.67 million units in the prospectus) at $4.25 each -the bottom […]